Zhejiang Conba Pharmaceutical Co., Ltd. (600572) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Conba Pharmaceutical Co., Ltd.

Why is Zhejiang Conba Pharmaceutical Co., Ltd. ?

With ROE of 8.17%, it has a very attractive valuation with a 1.62 Price to Book Value

Over the past year, while the stock has generated a return of 0.68%, its profits have fallen by -6.9%
At the current price, the company has a high dividend yield of 3.5

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Zhejiang Conba Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Conba Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Zhejiang Conba Pharmaceutical Co., Ltd.

-4.62%

-1.12

16.65%

China Shanghai Composite

16.67%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.23%

EBIT Growth (5y)

39.65%

EBIT to Interest (avg)

16.39

Debt to EBITDA (avg)

0.22

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.84

Tax Ratio

17.09%

Dividend Payout Ratio

60.90%

Pledged Shares

Institutional Holding

ROCE (avg)

8.79%

ROE (avg)

15.16%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.62

EV to EBIT

20.49

EV to EBITDA

12.00

EV to Capital Employed

1.69

EV to Sales

1.62

PEG Ratio

Dividend Yield

3.50%

ROCE (Latest)

8.23%

ROE (Latest)

8.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -9.57% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.58 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.39 times

EPS(Q)

Highest at CNY 0.09

-5What is not working for the Company

INTEREST(Q)

At CNY 1.95 MM has Grown at 11.47%

DEBT-EQUITY RATIO (HY)

Highest at -3.09 %

OPERATING PROFIT(Q)

Lowest at CNY 150.93 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.33 %

Here's what is working for Zhejiang Conba Pharmaceutical Co., Ltd.

EPS

Highest at CNY 0.09

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 2.58 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.39 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -9.57% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Conba Pharmaceutical Co., Ltd.

Interest

At CNY 1.95 MM has Grown at 11.47%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 150.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 9.33 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at -3.09 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio